Public Company

Aurobindo Pharma receives Swissmedic approval for cefepime for injection

Hyderabad-based Aurobindo Pharma Limited received approval from Swissmedic, an agency of Switzerland government for therapeutic products, for the licence of Cefepime APL for injection 1g and 2g. - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Sun Pharma invalidates Eli Lilly"s Gemzar patent - Glenmark"s drug fails clinical trials - Aurobindo Pharma up 2.4% - Aurobindo to acquire Trident Life This is used for moderate to severe pneumonia, septicaemia, skin and intra-abdominal infections. This is Auorbindo"s second product approval from Swissmedic, according to a press release. The company scrip was trading at Rs 730 on BSE, down 0.35 per cent compared to the previous day"s close of Rs 715.5.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
J K Lakshmi January sales up 38%
J K Lakshmi Cement today clocked a 38 per cent increase in sales at 5.06 lakh tonnes for the month of January, 2010.
Popular Articles
payday loans online

Google searches 3G prospects in India
Google, the world’s largest search engine and one of the biggest internet brands, is understood to be eyeing opportunities in the third generation of mobile telephony, or 3G, in India.
Polygraphy
Madhu Koda and his circle of friends
The first whiff that something had gone bad came 18 months ago, when officials from the Enforcement Directorate (ED) apprehended an individual at the Mumbai international airport as he was about to board an aircraft bound for Bangkok.

© Copyright 2009